ketamine has been researched along with Migraine with Aura in 3 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Migraine with Aura: A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Excerpt | Relevance | Reference |
---|---|---|
"Migraine aura is probably caused by cortical-spreading depression." | 5.31 | Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. ( Dichgans, M; Diener, HC; Herzog, J; Kaube, H; Käufer, T, 2000) |
"We review the published literature on migraine with prolonged aura (PA), specifically with regards to the phenotype and treatment options." | 2.58 | Migraine with prolonged aura: phenotype and treatment. ( Afridi, S; Viana, M, 2018) |
"Migraine aura is probably caused by cortical-spreading depression." | 1.31 | Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. ( Dichgans, M; Diener, HC; Herzog, J; Kaube, H; Käufer, T, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Viana, M | 1 |
Afridi, S | 1 |
Afridi, SK | 1 |
Giffin, NJ | 1 |
Kaube, H | 2 |
Goadsby, PJ | 1 |
Herzog, J | 1 |
Käufer, T | 1 |
Dichgans, M | 1 |
Diener, HC | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Ketamine for Refractory Chronic Migraine: a Pilot Study[NCT03896256] | Early Phase 1 | 6 participants (Actual) | Interventional | 2019-03-22 | Completed | ||
Intranasal Ketamine Versus Intranasal Midazolam Plus Fentanyl in Treating Pain Associated With Incision and Drainage of Abscesses in the Pediatric Emergency Department: A Randomized Controlled Trial[NCT02635282] | Phase 4 | 19 participants (Actual) | Interventional | 2016-08-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for ketamine and Migraine with Aura
Article | Year |
---|---|
Migraine with prolonged aura: phenotype and treatment.
Topics: Humans; Ketamine; Lamotrigine; Migraine with Aura; Phenotype; Pilot Projects; Randomized Controlled | 2018 |
1 trial available for ketamine and Migraine with Aura
Article | Year |
---|---|
A randomized controlled trial of intranasal ketamine in migraine with prolonged aura.
Topics: Administration, Intranasal; Adult; Analgesics; Double-Blind Method; Female; Humans; Inpatients; Keta | 2013 |
A randomized controlled trial of intranasal ketamine in migraine with prolonged aura.
Topics: Administration, Intranasal; Adult; Analgesics; Double-Blind Method; Female; Humans; Inpatients; Keta | 2013 |
A randomized controlled trial of intranasal ketamine in migraine with prolonged aura.
Topics: Administration, Intranasal; Adult; Analgesics; Double-Blind Method; Female; Humans; Inpatients; Keta | 2013 |
A randomized controlled trial of intranasal ketamine in migraine with prolonged aura.
Topics: Administration, Intranasal; Adult; Analgesics; Double-Blind Method; Female; Humans; Inpatients; Keta | 2013 |
1 other study available for ketamine and Migraine with Aura
Article | Year |
---|---|
Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine.
Topics: Administration, Intranasal; Adult; Calcium Channels, P-Type; Calcium Channels, Q-Type; Epilepsy; Exc | 2000 |